vs
百时美施贵宝(BMY)与WORLD KINECT CORP(WKC)财务数据对比。点击上方公司名可切换其他公司
百时美施贵宝的季度营收约是WORLD KINECT CORP的1.3倍($12.5B vs $9.7B),百时美施贵宝净利率更高(8.7% vs -0.0%,领先8.7%),WORLD KINECT CORP同比增速更快(2.0% vs 1.3%),百时美施贵宝自由现金流更多($1.6B vs $-60.2M),过去两年百时美施贵宝的营收复合增速更高(2.6% vs -6.0%)
百时美施贵宝是总部位于美国新泽西州普林斯顿的跨国制药企业,核心产品覆盖多个治疗领域:包括用于心房颤动治疗的艾乐妥(阿哌沙班)、抗癌药物欧狄沃(纳武利尤单抗)、治疗多发性骨髓瘤的瑞复美(来那度胺),以及用于类风湿性关节炎等自身免疫疾病的恩瑞舒(阿巴西普)。
世界科耐特公司(原世界燃料服务公司)是一家总部位于美国佛罗里达州多拉市的能源大宗商品服务企业,在2022年财富美国500强榜单中排名第70位。公司核心业务涵盖航空、海运、建筑及陆路运输领域能源大宗商品的销售、交易与融资及相关服务,2013年起也开展天然气与电力相关业务。
BMY vs WKC — 直观对比
营收规模更大
BMY
是对方的1.3倍
$9.7B
营收增速更快
WKC
高出0.7%
1.3%
净利率更高
BMY
高出8.7%
-0.0%
自由现金流更多
BMY
多$1.7B
$-60.2M
两年增速更快
BMY
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $12.5B | $9.7B |
| 净利润 | $1.1B | $-700.0K |
| 毛利率 | 67.2% | 2.8% |
| 营业利润率 | 11.8% | — |
| 净利率 | 8.7% | -0.0% |
| 营收同比 | 1.3% | 2.0% |
| 净利润同比 | 1409.7% | -250.0% |
| 每股收益(稀释后) | $0.54 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BMY
WKC
| Q1 26 | — | $9.7B | ||
| Q4 25 | $12.5B | $9.0B | ||
| Q3 25 | $12.2B | $9.4B | ||
| Q2 25 | $12.3B | $9.0B | ||
| Q1 25 | $11.2B | $9.5B | ||
| Q4 24 | $12.3B | $9.8B | ||
| Q3 24 | $11.9B | $10.5B | ||
| Q2 24 | $12.2B | $11.0B |
净利润
BMY
WKC
| Q1 26 | — | $-700.0K | ||
| Q4 25 | $1.1B | $-279.6M | ||
| Q3 25 | $2.2B | $25.7M | ||
| Q2 25 | $1.3B | $-339.4M | ||
| Q1 25 | $2.5B | $-21.1M | ||
| Q4 24 | $72.0M | $-101.8M | ||
| Q3 24 | $1.2B | $33.5M | ||
| Q2 24 | $1.7B | $108.3M |
毛利率
BMY
WKC
| Q1 26 | — | 2.8% | ||
| Q4 25 | 67.2% | 2.6% | ||
| Q3 25 | 71.9% | 2.7% | ||
| Q2 25 | 72.5% | 2.6% | ||
| Q1 25 | 72.9% | 2.4% | ||
| Q4 24 | 61.0% | 2.7% | ||
| Q3 24 | 75.1% | 2.6% | ||
| Q2 24 | 73.2% | 2.2% |
营业利润率
BMY
WKC
| Q1 26 | — | — | ||
| Q4 25 | 11.8% | -3.1% | ||
| Q3 25 | 25.5% | 0.7% | ||
| Q2 25 | 14.5% | -3.8% | ||
| Q1 25 | 26.5% | -0.1% | ||
| Q4 24 | 1.4% | 0.3% | ||
| Q3 24 | 14.1% | 0.7% | ||
| Q2 24 | 10.5% | 0.4% |
净利率
BMY
WKC
| Q1 26 | — | -0.0% | ||
| Q4 25 | 8.7% | -3.1% | ||
| Q3 25 | 18.0% | 0.3% | ||
| Q2 25 | 10.7% | -3.8% | ||
| Q1 25 | 21.9% | -0.2% | ||
| Q4 24 | 0.6% | -1.0% | ||
| Q3 24 | 10.2% | 0.3% | ||
| Q2 24 | 13.8% | 1.0% |
每股收益(稀释后)
BMY
WKC
| Q1 26 | — | $0.50 | ||
| Q4 25 | $0.54 | $-5.02 | ||
| Q3 25 | $1.08 | $0.46 | ||
| Q2 25 | $0.64 | $-6.06 | ||
| Q1 25 | $1.20 | $-0.37 | ||
| Q4 24 | $0.05 | $-1.70 | ||
| Q3 24 | $0.60 | $0.57 | ||
| Q2 24 | $0.83 | $1.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $10.2B | $151.1M |
| 总债务越低越好 | $44.8B | $798.7M |
| 股东权益账面价值 | $18.5B | $1.2B |
| 总资产 | $90.0B | $6.8B |
| 负债/权益比越低杠杆越低 | 2.43× | 0.66× |
8季度趋势,按日历期对齐
现金及短期投资
BMY
WKC
| Q1 26 | — | $151.1M | ||
| Q4 25 | $10.2B | $193.5M | ||
| Q3 25 | $15.7B | $473.6M | ||
| Q2 25 | $12.6B | $403.2M | ||
| Q1 25 | $10.9B | $456.4M | ||
| Q4 24 | $10.3B | $382.9M | ||
| Q3 24 | $7.9B | $373.8M | ||
| Q2 24 | $6.3B | $524.6M |
总债务
BMY
WKC
| Q1 26 | — | $798.7M | ||
| Q4 25 | $44.8B | $685.2M | ||
| Q3 25 | $48.7B | $766.6M | ||
| Q2 25 | $48.9B | $775.2M | ||
| Q1 25 | $49.5B | $792.3M | ||
| Q4 24 | $49.4B | $796.8M | ||
| Q3 24 | $49.5B | $798.0M | ||
| Q2 24 | $52.0B | $797.8M |
股东权益
BMY
WKC
| Q1 26 | — | $1.2B | ||
| Q4 25 | $18.5B | $1.3B | ||
| Q3 25 | $18.6B | $1.6B | ||
| Q2 25 | $17.4B | $1.6B | ||
| Q1 25 | $17.4B | $1.9B | ||
| Q4 24 | $16.3B | $1.9B | ||
| Q3 24 | $17.1B | $2.0B | ||
| Q2 24 | $17.0B | $2.0B |
总资产
BMY
WKC
| Q1 26 | — | $6.8B | ||
| Q4 25 | $90.0B | $5.9B | ||
| Q3 25 | $96.9B | $6.1B | ||
| Q2 25 | $94.7B | $6.1B | ||
| Q1 25 | $92.4B | $6.6B | ||
| Q4 24 | $92.6B | $6.7B | ||
| Q3 24 | $93.7B | $7.0B | ||
| Q2 24 | $94.6B | $7.2B |
负债/权益比
BMY
WKC
| Q1 26 | — | 0.66× | ||
| Q4 25 | 2.43× | 0.53× | ||
| Q3 25 | 2.63× | 0.47× | ||
| Q2 25 | 2.81× | 0.48× | ||
| Q1 25 | 2.85× | 0.41× | ||
| Q4 24 | 3.03× | 0.41× | ||
| Q3 24 | 2.89× | 0.39× | ||
| Q2 24 | 3.05× | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $2.0B | — |
| 自由现金流经营现金流 - 资本支出 | $1.6B | $-60.2M |
| 自由现金流率自由现金流/营收 | 12.8% | -0.6% |
| 资本支出强度资本支出/营收 | 3.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.82× | — |
| 过去12个月自由现金流最近4个季度 | $12.8B | $67.9M |
8季度趋势,按日历期对齐
经营现金流
BMY
WKC
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | $34.2M | ||
| Q3 25 | $6.3B | $116.1M | ||
| Q2 25 | $3.9B | $28.2M | ||
| Q1 25 | $2.0B | $114.4M | ||
| Q4 24 | $4.4B | $120.3M | ||
| Q3 24 | $5.6B | $-38.5M | ||
| Q2 24 | $2.3B | $67.9M |
自由现金流
BMY
WKC
| Q1 26 | — | $-60.2M | ||
| Q4 25 | $1.6B | $12.9M | ||
| Q3 25 | $6.0B | $102.0M | ||
| Q2 25 | $3.6B | $13.2M | ||
| Q1 25 | $1.7B | $99.2M | ||
| Q4 24 | $4.1B | $102.4M | ||
| Q3 24 | $5.3B | $-56.7M | ||
| Q2 24 | $2.1B | $53.3M |
自由现金流率
BMY
WKC
| Q1 26 | — | -0.6% | ||
| Q4 25 | 12.8% | 0.1% | ||
| Q3 25 | 49.0% | 1.1% | ||
| Q2 25 | 29.0% | 0.1% | ||
| Q1 25 | 15.1% | 1.0% | ||
| Q4 24 | 32.9% | 1.0% | ||
| Q3 24 | 44.3% | -0.5% | ||
| Q2 24 | 16.9% | 0.5% |
资本支出强度
BMY
WKC
| Q1 26 | — | 0.1% | ||
| Q4 25 | 3.0% | 0.2% | ||
| Q3 25 | 2.6% | 0.2% | ||
| Q2 25 | 2.9% | 0.2% | ||
| Q1 25 | 2.3% | 0.2% | ||
| Q4 24 | 3.1% | 0.2% | ||
| Q3 24 | 2.7% | 0.2% | ||
| Q2 24 | 2.1% | 0.1% |
现金转化率
BMY
WKC
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | — | ||
| Q3 25 | 2.87× | 4.52× | ||
| Q2 25 | 2.99× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 61.65× | — | ||
| Q3 24 | 4.62× | -1.15× | ||
| Q2 24 | 1.38× | 0.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BMY
| Net Product Sales | $12.1B | 97% |
| Zeposia | $159.0M | 1% |
| Opdivo Ovantig | $132.0M | 1% |
| Abecma | $100.0M | 1% |
| Sotyktu | $86.0M | 1% |
WKC
| Aviation segment | $5.0B | 52% |
| Land segment | $2.9B | 30% |
| Marine segment | $1.9B | 20% |